NCCN Guidelines to Include Categories of Preference

September 15, 2017 – The National Comprehensive Cancer Network® (NCCN®) has instituted Categories of Preference for recommendations within the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Initially, Categories of Preference will be published for drugs and biologics recommended within the NCCN Guidelines for Multiple Myeloma. Additional cancer types are forthcoming. All recommendations in the NCCN Guidelines for Multiple … (leggi tutto)